Pendrell News, Pendrell Quote, PCO Quote

Pendrell (NQ:PCO) Delayed: 6.97 --0 (-0%)

Prev. Close

$6.97

Open

$0.08

52 Wk High

$7.36

52 Wk Low

$0.45

Day High

$6.97

Day Low

$6.97

P/E

N/A

EPS

$-0.20

Volume

383,871

Friends, Peers and Foes (?): ZYUS, ZLSCF, RFHRF, CIA, KSIOF (more...)

Apr 23, 2024 07:00 AM ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management
Mar 5, 2024 07:00 AM Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now
Feb 1, 2024 07:00 AM ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke
Jan 9, 2024 07:00 AM Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now
Jan 9, 2024 07:00 AM ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research
Dec 5, 2023 07:00 AM ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management
Nov 29, 2023 10:48 PM ZYUS Life Sciences Corporation Reports Q3 2023 Results
Nov 21, 2023 07:45 AM ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels
Oct 24, 2023 07:00 AM ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets
Aug 31, 2023 07:45 AM ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

Entities mentioned with PCO